EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease

Ian D Gaudet, Hongyuan Xu, Emily Gordon, Gianna A Cannestro, Michael L Lu, Jianning Wei

Journal of Neuroinflammation · 2024

DOI: 10.1186/s12974-024-03038-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroinflammation, 2024. Verfasst von Ian D Gaudet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA. Hauptthemen laut MEDLINE: Huntington Disease, Nitrosative Stress. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously identified solute carrier family 7 member 2 (SLC7A2) as one of the top upregulated genes when normal Huntingtin was deleted. SLC7A2 has a high affinity for l -arginine. Arginine is implicated in inflammatory responses, and SLC7A2 is an important regulator of innate and adaptive immunity in macrophages. Although neuroinflammation is clearly demonstrated in animal models and patients with Huntington’s disease (HD), the question of whether neuroinflammation actively participates in HD pathogenesis is a topic of ongoing research and debate. Here, we studied the role of SLC7A2 in mediating the neuroinflammatory stress response in HD cells. RNA sequencing (RNA-seq), quantitative RT-PCR and data mining of publicly available RNA-seq datasets of human patients were performed to assess the levels of SLC7A2 mRNA in different HD cellular models and patients. Biochemical studies were then conducted on cell lines and primary mouse astrocytes to investigate arginine metabolism and nitrosative stress in response to neuroinflammation. The CRISPR–Cas9 system was used to knock out SLC7A2 in STHdhQ7 and Q111 cells to investigate its role in mediating the neuroinflammatory response. Live-cell imaging was used to measure mitochondrial dynamics. Finally, exploratory studies were performed using the Enroll-HD periodic human patient dataset to analyze the effect of arginine supplements on HD progression. We found that SLC7A2 is selectively upregulated in HD cellular models and patients. HD cells exhibit an overactive response to neuroinflammatory challenges, as demonstrated by abnormally high iNOS induction and NO production, leading to increased protein nitrosylation. Depleting extracellular Arg or knocking out SLC7A2 blocked iNOS induction and NO production in STHdhQ111 cells. We further examined the functional impact of protein nitrosylation on a well-documented protein target, DRP-1, and found that more mitochondria were fragmented in challenged STHdhQ111 cells. Last, analysis of Enroll-HD datasets suggested that HD patients taking arginine supplements progressed more rapidly than others. Our data suggest a novel pathway that links arginine uptake to nitrosative stress via upregulation of SLC7A2 in the pathogenesis and progression of HD. This further implies that arginine supplements may potentially pose a greater risk to HD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseNitrosative StressAnimalsHumansMiceAmino Acid Transport Systems, BasicArginineCell LineInflammationNeuroinflammatory Diseases

Stichwörter der Autor:innen

Arginine transporterHuntington’s diseaseNONeuroinflammationNitrosative stressNitrosylationSLC7A2iNOS

Substanzen

Amino Acid Transport Systems, BasicArginineSLC7A2 protein, humanSlc7a2 protein, mouse

Autor:innen und Institutionen

  • Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA.
  • Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA. jwei@health.fau.edu.

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gaudet, I. D., Xu, H., Gordon, E., Cannestro, G. A., Lu, M. L., & Wei, J. (2024). Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-024-03038-2

Vancouver

Gaudet ID, Xu H, Gordon E, Cannestro GA, Lu ML, Wei J. Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease. Journal of Neuroinflammation. 2024. doi:10.1186/s12974-024-03038-2

BibTeX
@article{Gaudet2024,
  author = {Gaudet, Ian D and Xu, Hongyuan and Gordon, Emily and Cannestro, Gianna A and Lu, Michael L and Wei, Jianning},
  title = {Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease},
  journal = {Journal of Neuroinflammation},
  year = {2024},
  doi = {10.1186/s12974-024-03038-2}
}
Kostenlos starten →